In prostate cancer cells, eHSP90 binds to LRP1 and promotes ERK signalling, leading to the impairment of E-cadherin function, the loss of junctional integrity and the induction of EMT [99, 100]. The gene discussed is LRP1; the disease is prostate carcinoma.